[…] cordless phone use J. Aust. Coll. Nutr. & Env. Med. Vol. 25 No. 2 August 2006 (accepted for publication) Â By Don Maisch EMFacts […]
ALL DECTs off hands! (and out of our lives!) Read More »
[…] cells that cause disease relapse Download PDF Copy March 2, 2017 at 3: 50 AM Chemotherapy treatment targets and kills cancer cells in the body. […]
Cancer STEM cells mechanism of propagation Read More »
[…] shortness of breath, chest pain and bloody mucus, according to the CDC. No Vaccine There is no vaccine available for plague in the U.S. […]
Again, weaponization of pathogens Read More »
Dr. Weeks’ Comment: There is a lot to be said, therapeutically, for putting some things behind you and focusing on the present goals and aspirations […]
What you focus on grows (no surprise) Read More »
[…] top 0.01 percent earned one percent of all the income. There is no consensus among economists on whether large disparities in income lead to […]
Great time to be rich…. (thanks to US Gov’t) Read More »
 Dr. Weeks’ Comment:  Berries, not Chemo!  Organic raspberries tremendously healthy but are hard to find – and expensive. The seeds are indigestible which is unfortunate […]
Berries, not Chemo and Radiation Read More »
[…] treatment for PTSD; whereas medications such as Paxil have shown 25 to 50 percent relapse rates. The report suggests that the escalating cost of […]
Analyze YOUR therapist! Read More »
[…] China, Russia, the Middle East, eastern Europe, Africa, Brazil, Paraguay and Venezuela.” No mas! – Leave Paraguay alone! The Republic of Paraguay is in […]
Milk Consumption Comparisons Read More »
[…] Related citations Select item 19141954101. Effects of thymoquinone and selenium on the proliferation of mg 63 cells in tissue culture. Barron J, Benghuzzi H, Tucci M. […]
Black cumin seed and cancer – more science that impresses! Read More »
[…] point of view, resveratrol is a natural substance and not patentable. Glaxo’s purchase of Sirtris, Dr. Vlasuk said, was more because the company afforded […]
Resveratrol – pros and cons. Read More »
